Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study

Owen A. Ross; Alexandra I. Soto‐Ortolaza; Michael G. Heckman; Jan Aasly; Nadine Abahuni; Grazia Annesi; Justin A. Bacon; Soraya Bardien; Maria Bozi; Alexis Brice; Laura Brighina; Christine Van Broeckhoven; Jonathan Carr; Marie‐Christine Chartier‐Harlin; Efthimios Dardiotis; Dennis W. Dickson; Nancy N. Diehl; Alexis Elbaz; Carlo Ferrarese; Alessandro Ferraris; Brian Fiske; J. Mark Gibson; Rachel A. Gibson; Georgios M. Hadjigeorgiou; Nobutaka Hattori; John P A Ioannidis; Barbara Jasińska‐Myga; Beom S. Jeon; Yun Joong Kim; Christine Klein; Rejko Krüger; Elli Kyratzi; Suzanne Lesage; Chin‐Hsien Lin; Timothy Lynch; Demetrius M. Maraganore; George D. Mellick; Eugénie Mutez; Christer Nilsson; Grzegorz Opala; Sung Sup Park; Andreas Puschmann; Aldo Quattrone; Manu Sharma; Peter A. Silburn; Young H. Sohn; Leonidas Stefanis; Vera Tadić; Jessie Theuns; Hiroyuki Tomiyama; Ryan J. Uitti; Enza Maria Valente; Simone van de Loo; Demetrios K. Vassilatis; Carles Vilariño‐Güell; Linda R. White; Karin Wirdefeldt; Zbigniew K. Wszołek; Ruey‐Meei Wu; Matthew J. Farrer

doi:10.1016/s1474-4422(11)70175-2

Related publications

Article2013

Population‐specific frequencies for <i>LRRK2</i> susceptibility variants in the genetic epidemiology of Parkinson's disease (GEO‐PD) consortium

Matthew J. Farrer, Owen A. Ross, Michael G. Heckman, Alexandra I. Soto‐Ortolaza, Jan Aasly, Nadine Abahuni, Grazia Annesi, Justin A. Bacon, Soraya Bardien, Maria Bozi, Alexis Brice, Laura Brighina, Jonathan Carr, Marie‐Christine Chartier‐Harlin, Efthimios Dardiotis, Dennis W. Dickson, Nancy N. Diehl, Alexis Elbaz, Carlo Ferrarese, Brian Fiske, Jonathan Gibson, Rachel A. Gibson, Georgios M. Hadjigeorgiou, Nobutaka Hattori, John P A Ioannidis, Magdalena Boczarska‐Jedynak, Barbara Jasińska‐Myga, Beom S. Jeon, Yun Joong Kim, Christine Klein, Rejko Krüger, Elli Kyratzi, Suzanne Lesage, Chin‐Hsien Lin, Timothy Lynch, Demetrius M. Maraganore, George D. Mellick, Eugénie Mutez, Christer Nilsson, Grzegorz Opala, Sung Sup Park, Simona Petrucci, Andreas Puschmann, Aldo Quattrone, Manu Sharma, Peter A. Silburn, Young H. Sohn, Leonidas Stefanis, Vera Tadić, Jessie Theuns, Hiroyuki Tomiyama, Ryan J. Uitti, Enza Maria Valente, Christine Van Broeckhoven, Simone van de Loo, Demetrios K. Vassilatis, Carles Vilariño‐Güell, Linda R. White, Karin Wirdefeldt, Zbigniew K. Wszołek, Ruey‐Meei Wu, Fayçal Hentati

Article2006

LRRK2 in Parkinson's disease and dementia with Lewy bodies.

Xiongwei Zhu, Asim K. Babar, Sandra L. Siedlak, Qiwei Yang, Genta Ito, Takeshi Iwatsubo, Mark A. Smith, George Perry, Shu G. Chen

Article2014

Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants.

Michael G. Heckman, Alexis Elbaz, Owen A. Ross, Matthew J. Farrer, Demetrius M. Maraganore, Georgia Xiromerisiou, Ruey Meei Wu, Zbigniew K. Wszołek, Karin Wirdefeldt, Linda R. White, Carles Vilariño‐Güell, Demetrios K. Vassilatis, Enza Maria Valente, Ryan J. Uitti, Hiroyuki Tomiyama, Vera Tadić, Leonidas Stefanis, Young H. Sohn, Peter A. Silburn, Manu Sharma, Aldo Quattrone, Simona Petrucci, Sung Sup Park, Grzegorz Opala,

Article2013

The protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants

Michael G. Heckman, Alexis Elbaz, Alexandra I. Soto‐Ortolaza, Daniel Serie, Jan Aasly, Grazia Annesi, Georg Auburger, Justin A. Bacon, Magdalena Boczarska‐Jedynak, Maria Bozi, Laura Brighina, Marie‐Christine Chartier‐Harlin, Efthimios Dardiotis, A. Destée, Carlo Ferrarese, Alessandro Ferraris, Brian Fiske, Suzana Gispert, Georgios M. Hadjigeorgiou, Nobutaka Hattori, John P A Ioannidis, Barbara Jasińska‐Myga, Beom S. Jeon,

Article2009

Are oxidative stress markers useful to predict clinical progression in Parkinson’s disease? A case-control study

Rcs Seet, Jetty Chung‐Yung Lee, Ech Lim, Jjh Tan, Aml Quek, WL Chong, WF Looi, Hong‐Li Huang, S.-M. Huang, Barry Halliwell